About this Research Topic
Skeletal muscle and cardiovascular diseases pose significant challenges to public health, impacting individuals across diverse demographics. Despite traditional therapeutic interventions, there is a critical need for advanced treatments to address the complex nature of these conditions. Cellular and Gene Therapy have opened new avenues for exploring innovative approaches to managing these diseases. In recent years, several gene and cell therapies have gained approval from regulatory agencies, signaling a significant milestone in the field and opening up a promising avenue of opportunities for treatment. These approvals underscore the growing recognition of the potential of gene and cell therapy to advance the management of skeletal muscle and cardiovascular diseases, offering better.
This Research Topic aims to provide insights into the latest advances in gene and cell therapy for skeletal muscle and cardiovascular diseases, from the bench to the patient's bedside. Authors are encouraged to explore the following key themes:
- Novel vector designs tailored for muscular applications;
- Novel vector designs tailored for regenerative therapies applications;
- Cutting-edge gene editing techniques targeting muscle cells and cardiac lineage;
- Strategies for reducing fibrosis and/ or improve angio-vasculogenesis through gene or cell-based interventions;
- Harnessing the potential of skeletal and cardiac muscle stem cells for therapeutic purposes;
- Advancements in ex vivo and in vivo gene therapy approaches for muscular or cardiovascular disorders;
- Innovative strategies for promoting tissue regeneration through gene and cell therapy modalities;
-Tissue-engineering approaches to skeletal or cardiac repair.
We welcome submissions, though not limited, from the following article types: Original Research Articles, Reviews, Mini Reviews, and Opinion.
This Research Topic aims to provide insights into the latest advances in gene and cell therapy for skeletal muscle and cardiovascular diseases, from the bench to the patient's bedside. Authors are encouraged to explore the following key themes:
- Novel vector designs tailored for muscular applications;
- Novel vector designs tailored for regenerative therapies applications;
- Cutting-edge gene editing techniques targeting muscle cells and cardiac lineage;
- Strategies for reducing fibrosis and/ or improve angio-vasculogenesis through gene or cell-based interventions;
- Harnessing the potential of skeletal and cardiac muscle stem cells for therapeutic purposes;
- Advancements in ex vivo and in vivo gene therapy approaches for muscular or cardiovascular disorders;
- Innovative strategies for promoting tissue regeneration through gene and cell therapy modalities;
-Tissue-engineering approaches to skeletal or cardiac repair.
We welcome submissions, though not limited, from the following article types: Original Research Articles, Reviews, Mini Reviews, and Opinion.
Keywords: Gene Therapy, Skeletal muscle, Cardiovascular diseases, Cell therapy, Regenerative Medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
